Fischer Medical

{
  "main_header": {
    "sid": 608735,
    "name": "Fischer Medical",
    "stock_name": "Fischer Medical",
    "full_name": "Fischer Medical Ventures Ltd",
    "name_url": "stocks-analysis/fischer-medical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "44.22",
    "chg": 2.1,
    "chgp": "4.99%",
    "dir": 1,
    "prev_price": "42.12",
    "mcapval": "2,783.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524743,
    "symbol": "FISCHER",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE771F01041",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "16.6 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fischer-medical-608735-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Fischer Medical Ventures Ltd Gains 14.65%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-ltd-gains-1465-5-key-factors-driving-the-surge-3826498",
        "imagepath": "",
        "date": "2026-02-07 16:09:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens weak at Rs.36.60, down 5.11%</p>\n                    <p><strong>3 Feb:</strong> Surges to upper circuit at Rs.38.43 (+5.00%)</p>\n                    <p><strong>4 Feb:</strong> Hits upper circuit again at Rs.40.35 (+5.00%)</p>\n                    <p><strong>5 Feb:</strong> Upgraded to Hold; price rises 5.00% to Rs.40.35</p>\n                    <p><strong>6 Feb:</strong> Upper circuit hit at Rs.44.22 (+4.99%) with strong volume</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.38.57</div></div>\n                    <div class=\"stat..."
      },
      {
        "title": "Fischer Medical Ventures Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-ltd-hits-upper-circuit-amid-robust-buying-pressure-3824525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_stocks_hitting_upper_circuit_3824525.png",
        "date": "2026-02-06 15:00:10",
        "description": "Fischer Medical Ventures Ltd, a small-cap player in the commodity chemicals sector, surged to hit its upper circuit limit on 6 Feb 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹44.09, marking a maximum daily gain of 4.99%, significantly outperforming its sector and the broader market indices."
      },
      {
        "title": "Fischer Medical Ventures Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fischer-medical-ventures-ltd-upgraded-to-hold-on-technical-and-financial-improvements-3821841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_mojoScore_3821841.png",
        "date": "2026-02-05 08:16:04",
        "description": "Fischer Medical Ventures Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement in its technical indicators and financial performance despite ongoing valuation concerns and management efficiency challenges. The upgrade, effective from 4 February 2026, is driven primarily by a shift in technical trends and steady quarterly financial results, signalling cautious optimism among analysts."
      },
      {
        "title": "Fischer Medical Ventures Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3821666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_technicaldot_3821666.png",
        "date": "2026-02-05 08:02:52",
        "description": "Fischer Medical Ventures Ltd has experienced a notable shift in its technical parameters, signalling a subtle change in price momentum despite a complex mix of bullish and bearish indicators. The stock’s recent 5.00% day gain to ₹40.35, coupled with an upgrade in its Mojo Grade from Sell to Hold, highlights evolving market sentiment amid a challenging commodity chemicals sector backdrop."
      },
      {
        "title": "Fischer Medical Ventures Ltd Surges to Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-3820183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_stocks_hitting_upper_circuit_3820183.png",
        "date": "2026-02-04 10:00:29",
        "description": "Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, surged to hit its upper circuit limit on 4 February 2026, closing at ₹40.27, marking a 4.98% gain on the day. This sharp rally was driven by robust buying interest, significant unfilled demand, and a regulatory freeze on further trading, underscoring heightened investor enthusiasm despite a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Fischer Medical Ventures Ltd Surges to Upper Circuit on Robust Buying Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-ltd-surges-to-upper-circuit-on-robust-buying-momentum-3818526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_stocks_hitting_upper_circuit_3818526.png",
        "date": "2026-02-03 12:00:12",
        "description": "Fischer Medical Ventures Ltd, a small-cap player in the commodity chemicals sector, surged to hit its upper circuit limit on 3 February 2026, propelled by robust buying interest and a significant intraday gain of 4.98%. The stock’s performance outpaced both its sector and the broader Sensex, signalling renewed investor confidence despite a recent downgrade in its mojo grade."
      },
      {
        "title": "Fischer Medical Ventures Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fischer-medical-ventures-ltd-is-rated-sell-3813992",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FischerMedicalV_mojoScore_3813992.png",
        "date": "2026-02-01 10:10:56",
        "description": "Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Fischer Medical Ventures Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fischer-medical-ventures-ltd-latest-results-good-or-bad-3813320",
        "imagepath": "",
        "date": "2026-01-31 19:21:11",
        "description": "Fischer Medical Ventures Ltd has reported substantial financial results for Q3 FY26, showcasing a remarkable transformation from its previous focus on commodity chemicals to medical diagnostic equipment trading. The company achieved net sales of ₹101.10 crores, reflecting a significant year-on-year growth of 760.43% compared to ₹11.75 crores in Q3 FY25. This quarter also marked the highest revenue in the company's history, with a sequential growth of 17.14% from the preceding quarter.\n\nNet profit for Q3 FY26 reached ₹19.23 crores, a dramatic increase from the previous year's loss, indicating a successful pivot in its business model. The operating margin improved to 21.34%, the highest recorded, while the PAT margin expanded to 19.02%, further highlighting the company's operational efficiency gains.\n\nDespite these impressive financial metrics, the company has experienced a decline in investor sentiment, as e..."
      },
      {
        "title": "Fischer Medical Ventures Gains 8.77%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fischer-medical-ventures-gains-877-5-key-factors-driving-the-weeks-rally-3813069",
        "imagepath": "",
        "date": "2026-01-31 16:08:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock hits 52-week low of Rs.33.94 and lower circuit amid heavy selling pressure</p>\n                    <p><strong>28 Jan:</strong> Further 52-week low recorded at Rs.33.1 despite broader market gains</p>\n                    <p><strong>30 Jan:</strong> Stock surges to upper circuit, closing at Rs.38.57 with strong buying momentum</p>\n                    <p><strong>30 Jan:</strong> Q3 FY26 results reveal stellar profit growth masking valuation concerns</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.35.46</div></div>\n                    ..."
      }
    ],
    "total": 731,
    "sid": "608735",
    "stock_news_url": "https://www.marketsmojo.com/news/fischer-medical-ventures-608735"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "06-Feb-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on February 06 2026 for Shankar Varadharajan",
      "source": "BSE"
    },
    {
      "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
      "datetime": "06-Feb-2026",
      "details": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on February 06 2026 for Shankar Varadharajan",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "30-Jan-2026",
      "details": "Announcement under Reg 30- Resignation of Company Secretary",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fischer Medical Ventures Ltd has announced <strong>1:10</strong> stock split, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fischer Medical Ventures Ltd Gains 14.65%: 5 Key Factors Driving the Surge

2026-02-07 16:09:50

Key Events This Week

2 Feb: Stock opens weak at Rs.36.60, down 5.11%

3 Feb: Surges to upper circuit at Rs.38.43 (+5.00%)

4 Feb: Hits upper circuit again at Rs.40.35 (+5.00%)

5 Feb: Upgraded to Hold; price rises 5.00% to Rs.40.35

6 Feb: Upper circuit hit at Rs.44.22 (+4.99%) with strong volume

Week Open

Rs.38.57

Read full news article

Fischer Medical Ventures Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-02-06 15:00:10

Fischer Medical Ventures Ltd, a small-cap player in the commodity chemicals sector, surged to hit its upper circuit limit on 6 Feb 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹44.09, marking a maximum daily gain of 4.99%, significantly outperforming its sector and the broader market indices.

Read full news article

Fischer Medical Ventures Ltd Upgraded to Hold on Technical and Financial Improvements

2026-02-05 08:16:04

Fischer Medical Ventures Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement in its technical indicators and financial performance despite ongoing valuation concerns and management efficiency challenges. The upgrade, effective from 4 February 2026, is driven primarily by a shift in technical trends and steady quarterly financial results, signalling cautious optimism among analysts.

Read full news article

Fischer Medical Ventures Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-05 08:02:52

Fischer Medical Ventures Ltd has experienced a notable shift in its technical parameters, signalling a subtle change in price momentum despite a complex mix of bullish and bearish indicators. The stock’s recent 5.00% day gain to ₹40.35, coupled with an upgrade in its Mojo Grade from Sell to Hold, highlights evolving market sentiment amid a challenging commodity chemicals sector backdrop.

Read full news article

Fischer Medical Ventures Ltd Surges to Upper Circuit Amid Strong Buying Pressure

2026-02-04 10:00:29

Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, surged to hit its upper circuit limit on 4 February 2026, closing at ₹40.27, marking a 4.98% gain on the day. This sharp rally was driven by robust buying interest, significant unfilled demand, and a regulatory freeze on further trading, underscoring heightened investor enthusiasm despite a recent downgrade in its Mojo Grade to Sell.

Read full news article

Fischer Medical Ventures Ltd Surges to Upper Circuit on Robust Buying Momentum

2026-02-03 12:00:12

Fischer Medical Ventures Ltd, a small-cap player in the commodity chemicals sector, surged to hit its upper circuit limit on 3 February 2026, propelled by robust buying interest and a significant intraday gain of 4.98%. The stock’s performance outpaced both its sector and the broader Sensex, signalling renewed investor confidence despite a recent downgrade in its mojo grade.

Read full news article

Fischer Medical Ventures Ltd is Rated Sell

2026-02-01 10:10:56

Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Fischer Medical Ventures Ltd latest results good or bad?

2026-01-31 19:21:11

Fischer Medical Ventures Ltd has reported substantial financial results for Q3 FY26, showcasing a remarkable transformation from its previous focus on commodity chemicals to medical diagnostic equipment trading. The company achieved net sales of ₹101.10 crores, reflecting a significant year-on-year growth of 760.43% compared to ₹11.75 crores in Q3 FY25. This quarter also marked the highest revenue in the company's history, with a sequential growth of 17.14% from the preceding quarter. Net profit for Q3 FY26 reached ₹19.23 crores, a dramatic increase from the previous year's loss, indicating a successful pivot in its business model. The operating margin improved to 21.34%, the highest recorded, while the PAT margin expanded to 19.02%, further highlighting the company's operational efficiency gains. Despite these impressive financial metrics, the company has experienced a decline in investor sentiment, as e...

Read full news article

Fischer Medical Ventures Gains 8.77%: 5 Key Factors Driving the Week’s Rally

2026-01-31 16:08:00

Key Events This Week

27 Jan: Stock hits 52-week low of Rs.33.94 and lower circuit amid heavy selling pressure

28 Jan: Further 52-week low recorded at Rs.33.1 despite broader market gains

30 Jan: Stock surges to upper circuit, closing at Rs.38.57 with strong buying momentum

30 Jan: Q3 FY26 results reveal stellar profit growth masking valuation concerns

Week Open

Rs.35.46

...

Read full news article

View All News